Mid-Day Commentary & Reports for : (NASDAQ: PPHM), (NYSE: STP)
Peregrine Pharmaceuticals (NASDAQ: PPHM), a biopharmaceutical company engaged in the research and development of monoclonal antibodies for the treatment and diagnosis of cancer and viral infections, is down in trading today, following the huge rally in the previous trading session.
View full press release